Research graph
References from Prostate tumor progression and prognosis. Local targets link to admitted publications; unresolved targets remain external evidence.
Cancer metastasis
10.1093/oxfordjournals.bmb.a072453 · 1991 · External reference
Critical determinants of cancer metastasis
10.1007/s002800051091 · 1999 · External reference
American Society for Therapeutic Radiology and Oncology Consensus Panel
1997 · External reference
Comparison of radical prostatectomy and iodine 125 interstitial radiotherapy for the treatment of clinically localized prostate cancer
10.1016/s0090-4295(98)00153-8 · 1998 · External reference
Therapeutic radiation in patients with a rising post-prostatectomy PSA level
1998 · External reference
Prognostic markers in localized prostate cancer
10.1023/a:1006137721823 · 1998 · External reference
Prostate cancer
1997 · External reference
Diagnostic and prognostic markers for human prostate cancer
10.1002/(sici)1097-0045(19970601)31:4<264::aid-pros8>3.0.co;2-k · 1997 · External reference
Unresolved reference
External reference
Unresolved reference
External reference
The multistep nature of cancer
10.1016/0168-9525(93)90209-z · 1993 · External reference
Mechanisms of tumor progression
1986 · External reference
Dominance of metastatically competent cells in primary murine breast neoplasms is necessary for distant metastatic spread
10.1002/ijc.2910470121 · 1991 · External reference
Reduction of TGF-beta activity abrogates growth promoting tumor cell-cell interactions in vivo
10.1002/jcp.1041480308 · 1991 · External reference
Neuroendocrine differentiation in prostatic carcinoma
10.1002/(sici)1097-0045(19990501)39:2<135::aid-pros9>3.0.co;2-s · 1999 · External reference
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors
10.1002/(sici)1097-0045(1998)8+<43::aid-pros8>3.0.co;2-h · 1998 · External reference
Cathepsin D and chromogranin A as predictors of long term disease specific survival after radical prostatectomy for localized carcinoma of the prostate
10.1002/(sici)1097-0142(19971201)80:11<2109::aid-cncr10>3.0.co;2-2 · 1997 · External reference
Prognostic significance of neuroendocrine differentiation in clinically localized prostatic carcinoma
10.1002/(sici)1097-0045(1998)8+<37::aid-pros7>3.0.co;2-d · 1998 · External reference
Neuroendocrine differentiation in prostate cancer
10.1016/s0046-8177(96)90398-6 · 1996 · External reference
Vascular endothelial growth factor (VEGF) expression in prostatic tumours and its relationship to neuroendocrine cells
10.1038/bjc.1996.456 · 1996 · External reference
Acquisition of neuroendocrine characteristics by prostate tumor cells is reversible
1999 · External reference
Tumor dormancy in vivo by prevention of neovascularization
10.1084/jem.136.2.261 · 1972 · External reference
Metastasis and angiogenesis
10.3109/02841869009089997 · 1990 · External reference
Sequential development of an angiogenic phenotype by human fibroblasts progressing to tumorigenicity
10.1038/sj.onc.1200977 · 1997 · External reference
Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer
10.1016/0046-8177(95)90122-1 · 1995 · External reference
Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma
10.1006/exer.1996.0141 · 1996 · External reference
Optimized microvessel density analysis improves prediction of cancer stage from prostate needle biopsies
10.1016/s0090-4295(96)00149-5 · 1996 · External reference
Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia
1995 · External reference
Predictors of pathologic stage in prostatic carcinoma. The role of neovascularity
10.1002/1097-0142(19940201)73:3<678::aid-cncr2820730329>3.0.co;2-6 · 1994 · External reference
p53, bcl-2 and retinoblastoma proteins as long-term prognostic markers in localized carcinoma of the prostate
10.1097/00005392-199707000-00040 · 1997 · External reference
Microvessel density, p53, retinoblastoma, and chromogranin a immunohistochemistry as predictors of disease-specific survivial following radical prostatectomy for carcinoma of the prostate
10.1016/s0090-4295(99)00598-1 · 2000 · External reference
Tumor induction of VEGF promoter activity in stromal cells
10.1016/s0092-8674(00)81731-6 · 1998 · External reference
Quantitative angiogenesis assays
10.1038/nm1197-1203 · 1997 · External reference
Fractal characteristics of tumor vascular architecture during tumor growth and regression
10.3109/10739689709146803 · 1997 · External reference
Role of tumor vascular architecture in nutrient and drug delivery
10.1006/mvre.1996.0031 · 1996 · External reference
Targeting gene expression to hypoxic tumor cells
10.1038/nm0597-515 · 1997 · External reference
Morphology of prostate cancer
10.1016/s0022-5347(17)32368-6 · 1994 · External reference
Clinical relevance of the individual prostate cancer focus
10.3109/07357909409038236 · 1994 · External reference
Multiple cancers in the prostate. Morphologic features of clinically recognized versus incidental tumors
10.1002/1097-0142(19921101)70:9<2313::aid-cncr2820700917>3.0.co;2-t · 1992 · External reference
Histological grade heterogeneity in multifocal prostate cancer. Biological and clinical implications
10.1002/(sici)1096-9896(199611)180:3<295::aid-path663>3.0.co;2-w · 1996 · External reference
Precise microdissection of human prostate cancers reveals genotypic heterogeneity
1998 · External reference
Independent origin of multiple foci of prostatic intraepithelial neoplasia
10.1002/(sici)1097-0142(19981101)83:9<1995::aid-cncr16>3.0.co;2-2 · 1998 · External reference
Genetic heterogeneity in a prostatic carcinoma and associated prostatic intraepithelial neoplasia as demonstrated by combined use of laser-microdissection, degenerate oligonucleotide primed PCR and comparative genomic hybridization
10.1007/s004280050252 · 1998 · External reference
Allelic loss on chromosome 8p12-21 in microdissected prostatic intraepithelial neoplasia
1995 · External reference
Aneuploidy index in blood
10.1016/s0090-4295(98)00487-7 · 1999 · External reference
Specific histologic and cytogenetic evidence for in vivo malignant transformation of murine host cells by three human prostate cancer cell lines
1997 · External reference
Genetic and epigenetic influences in prostatic carcinogenesis
1998 · External reference
The role of stromal-epithelial interaction in normal and malignant growth
1995 · External reference
Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts
1991 · External reference
Elevated transforming growth factor-beta 1 and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate
10.1210/mend-5-4-503 · 1991 · External reference
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
10.1016/0092-8674(89)90625-9 · 1989 · External reference
Genetic predisposition and mesenchymal-epithelial interactions in ras+myc-induced carcinogenesis in reconstituted mouse prostate
10.1002/mc.2940070307 · 1993 · External reference
Development of seven new human prostate tumor xenograft models and their histopathological characterization
1996 · External reference
Identification of bone marrow micrometastases in patients with prostate cancer
10.1002/1097-0142(19941101)74:9<2533::aid-cncr2820740922>3.0.co;2-d · 1994 · External reference
Detection of micrometastatic prostate cancer cells in the bone marrow of patients with prostate cancer
10.1038/bjc.1997.114 · 1997 · External reference
Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction
10.1016/s0022-5347(01)61592-1 · 1999 · External reference
Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer
1999 · External reference
Osteonectin promotes prostate cancer cell migration and invasion
1999 · External reference
Osteopontin
1999 · External reference
Plasma levels of vascular endothelial growth factor are increased in patients with metastatic prostate cancer
10.1016/s0090-4295(99)00167-3 · 1999 · External reference
